SlideShare a Scribd company logo
Continue Dx Test Evaluation
DR Amita Kashyap
Sr. Prof. PSM
SMS Med College Jaipur
Decide whether to order ESR or directly do MRI?
• A 57 yr old man presents with h/o aching low back pain
that persists at rest and is worse by bending and lifting.
• Progressively getting worse in last 6 wks-waking from sleep.
• Within past 10 days he has noticed numbness in Rt buttock
and thigh and weakness in Rt lower limb.
• He had no fever but has lost 10 lb Wt. in last 4 months.
• O/E Temp. is 99.6F, tenderness in the lower lumber spine,
decrease sensation over dorso-lateral aspect of Rt. foot,
weakness in Rt ankle aversion. Deep tendon reflexes Norm.
• You suspect that man has 20% chance of spinal Malignancy
• ESR ≥20 mm/h has 78% sensitivity & 67% specificity
• MRI has 95% sensitivity AND 95% specificity!!
• Suppose we have 1000 patients
We can use any of the following methods
• 2 X 2 Table Method
• Likelihood Ratio (gives odds)
• Decision Tree method And
• Bayes Theoram
How will the prior probability of 20% Change with +ve ESR
(78% sensitivity & 67% specificity) 2X2 Table method
Disease
Test
(ESR)
D+ D-
T+ (TP)
156
(FP)
264
420
T- (FN)
44
(TN)
536
580
200 800 1000
Predictive Value of a Positive test
PPV (PV+) = 156/420 = 0.37
Increased from 20% to 37%
Predictive Value of a Negative test
NPV = 536/580 = 0.92
A) - What is the probability of FP Rate ?
B)- What is the probability of FN Rate?
A) - 264/420 = 0.63 (hence minimal use as screening test),
B) - 44/580 = 0.08
MRI has 95% sensitivity AND 95% specificity
And will have PVs as follows:-
Disease
Test (MRI) D+ D-
T+ (TP) 351.5 (FP) 31.5 383
T- (FN) 18.5 (TN) 598.5 617
370 630 1000
PPV (PV+) = 351.5/383 = 0.918
FP Rate = 31.5/383 = 0.08
NPV (NPV) = 598.5/617= 0.970
FN Rate = 18.5/ 617 = 0.03
• Definition: An LR is the probability of a particular test
result for a persons with the disease divided by the
probability of that test result in non-diseased persons
How will the prior probability of 20% change with +ve ESR?
Likelihood Ratio Method
LR+ =
Probability of +ve test result in Diseased persons
(True positive / total diseased i.e. Sensitivity)
Probability of +ve test result in Disease Free persons
(False positive/ total Non-diseased i.e. 1- Specificity)
LR¯ =
Probability of -ve test result in Diseased persons
(False Negative / total diseased i.e. 1- Sensitivity)
Probability of -ve test result in Disease Free persons
(True negatives/ total Non-diseased i.e. Specificity)
LR+ = Sensitivity / 1-specificity
= 0.78 / 1-0.67
= 0.78 / 0.33 = 2.36
LR¯ - 1-Sensitivity) / Specificity
= 1- 0.78 / 0.67
= 0.22/ 0.67 = 0.328
With ESR having 78% sensitivity & 67% specificity
Pre Test odds = Prior Probability
1- Prior Probability
Post Test odds = LR X Pre test odds
= 2.36 X 0.25 = 0.59
Posterior probability (PPV)
= post test odds/ 1+ post test odds
= 0.59/ 1+ 0.59 = 0.37 = 37%
Likelihood Ratio to
Post Test Probability
= 0.20 /1- 0.2 = 0.25
Pre Test odds (with 20% Prev)
0.3
13
20 40 60 80 100
64
After positive
FNA result
54 yr old women
Before Mammogram
After positive
mammogram
Probability of Breast Cancer (Percent)
palpable lump
Prior to
mammogram
Estimated Probability of Breast Cancer
1) In a 54 yr old women without palpable Breast Mass,
2) After a positive mammogram and
3) Following a positive FNA test result
1% with
H/o Br Ca
In mother
How will the prior probability of 13% Change
2X2 Table method
Surgical Biopsy
Cancer No Cancer
FNA
Result
+
-
Total 15 99
22
92
114
Total
Prevalence = 13%
Sensitivity = 93%
Specificity = 92%
PPV = 64%
NPV = 99%
LR+ = Sensitivity / 1-specificity
= 0.93 / 1-0.92
= 0.93 / 0.08 = 11.63
LR¯ - 1-Sensitivity) / Specificity
= 1- 0.93 / 0.92
= 0.07/ 0.92 = 0.08
With FNA having 93% sensitivity & 92% specificity
In contrast to PV, LR does not vary as a function of Prevalence
Pre Test odds = Prior Probability
1- Prior Probability
Post Test odds = LR X Pre test odds
= 11.63 X 0.15 = 1.74
Posterior probability (PPV)
= post test odds/ 1+ post test odds
= 1.74/ 1+ 1.74 = 0.64 = 64%
Likelihood Ratio to
Post Test Probability
= 0.13 /1- 0.13 = 0.15
Pre Test odds (with 13 % Prev)
Receiver Operating Characteristic (ROC) Curve
• Diagnostic tests giving quantitative outcome e.g.
serum levels of enzymes, there are many options
about where to set a cut off point – as the cut off
point rises (from 200 to 250mg/dl for total cholesterol)
the sensitivity will increase with a corresponding
decrease in specificity.
•To get a most suitable cutoff point at each cutoff
point, sensitivity and (1- specificity) are calculated
and plotted on ‘y’ and ‘x’ axis respectively along
the full range of cutoff points
Test Result
without the disease
with the disease
‘‘-’’ ‘‘+’’
Moving the Threshold: right
Test Result
without the disease
with the disease
‘‘-’’ ‘‘+’’
Moving the Threshold: left
1 0
%1s
%0s
Say
1
Say
0
Say
1
Say
0
Say
1
Say
0
Say
1
Say
0
Say
0
Say
1
Say
1
Say
0
Say
1
Say
0
Say
0
Say
1
True
Positive
Rate
0%
100%
False Positive Rate
0
%
100%
True
Positive
Rate
0%
100%
False Positive Rate
0% 100%
A good test: A poor test:
ROC curve comparison
Best Test: Worst test:
True
Positive
Rate
0
%
100%
False Positive Rate
0
%
100
%
True
Positive
Rate
0
%
100%
False Positive
Rate
0
%
100
%
The distributions
don’t overlap at all
The distributions
overlap completely
ROC curve extremes
Reliability or Repeatability of a Test
• Factors responsible for variation in the results:
1. Intra subject (within the individual) variation
2. Intra observer variation (variation in the
reading of test result by the same observer)-
greater the subjective element in the reading
more is this error
3. Inter observer variation (variation in the
reading of test result between observers)
Inter observer Variation
Reading
No. 1
Reading No.
2
Abnormal Suspect Doubtful Normal
Abnormal A B C D
Suspect E F G H
Doubtful I J K L
Normal M N O P
Percent Agreement =
A + F + K + P
Total readings
X 100
In general, most persons who are tested have Negative Test Result,
& there is likely to be Considerable agreement on this
Ob 1
Ob 1
Kappa Statistics
• The extent to which two observers (physician/
nurse/ radiologist/ Dx Test) agree is an important
Index of good quality of care
• Yet, there is a fraction based ‘solely on chance’
for agreement between two observers
• What we want to know is – to what extent did
the education/ training that the observers
received improve the quality of their observation
(how much increased percent agreement
between them beyond chance! )
Rationale of the kappa statistics
• First find out– “how much better is the agreement
between the observers’ readings than would be
expected by chance”
i.e. = (% agreement observed - % agreement
expected by Chance alone)
• We Know that the maximum improvement the
observers can have than expected by chance is:-
100% - % agreement expected by Chance alone
• Kappa Statistics expresses the extent to which
the observed agreement exceeds chance
agreement relative to maximum that the
observer can hope to improve
• Kappa =
[Percent Agreement
Observed]
[ Percent Agreement
expected by chance alone ]
-
[ Percent Agreement
expected by chance alone ]
100% -
Landis and Koch suggested that :-
kappa greater than 0.75 = excellent agreement
Kappa of 0.40 to 0.75 = intermediate to good agreement
Histological grading
Of lung cancer by
two pathologist
Likelihood Ratio, ROC and kappa

More Related Content

What's hot

Odds ratios (Basic concepts)
Odds ratios (Basic concepts)Odds ratios (Basic concepts)
Odds ratios (Basic concepts)
Tarekk Alazabee
 
Chi-square, Yates, Fisher & McNemar
Chi-square, Yates, Fisher & McNemarChi-square, Yates, Fisher & McNemar
Chi-square, Yates, Fisher & McNemar
Azmi Mohd Tamil
 
Pearson Correlation, Spearman Correlation &Linear Regression
Pearson Correlation, Spearman Correlation &Linear RegressionPearson Correlation, Spearman Correlation &Linear Regression
Pearson Correlation, Spearman Correlation &Linear Regression
Azmi Mohd Tamil
 
1.5.3 measures prevalence
1.5.3 measures prevalence1.5.3 measures prevalence
1.5.3 measures prevalence
A M
 
Epidemiological study designs
Epidemiological study designsEpidemiological study designs
Epidemiological study designs
Kayode Afolabi
 
Causal Inference PowerPoint
Causal Inference PowerPointCausal Inference PowerPoint
Causal Inference PowerPoint
emphemory
 
Sample size calculation final
Sample size calculation finalSample size calculation final
Sample size calculation final
Bhaswat Chakraborty
 
Study design
Study designStudy design
Screening
ScreeningScreening
Screening
Dalia El-Shafei
 
Chapter 2.2 screening test
Chapter 2.2 screening testChapter 2.2 screening test
Chapter 2.2 screening test
Nilesh Kucha
 
Nested case control study
Nested case control studyNested case control study
Nested case control study
Prayas Gautam
 
Reliability and validity
Reliability and validityReliability and validity
Reliability and validity
Kaimrc_Rss_Jd
 
Introduction to Epidemiology and Surveillance
Introduction to Epidemiology and SurveillanceIntroduction to Epidemiology and Surveillance
Introduction to Epidemiology and Surveillance
George Moulton
 
Cross-Sectional Study.pptx
Cross-Sectional Study.pptxCross-Sectional Study.pptx
Cross-Sectional Study.pptx
AB Rajar
 
Association and causation
Association and causationAssociation and causation
Association and causation
Aparna Chaudhary
 
Measuring Disease Frequency
Measuring Disease FrequencyMeasuring Disease Frequency
Measuring Disease Frequency
Akhilesh Bhargava
 
ODDS RATIO AND RELATIVE RISK EVALUATION
ODDS RATIO AND RELATIVE RISK EVALUATIONODDS RATIO AND RELATIVE RISK EVALUATION
ODDS RATIO AND RELATIVE RISK EVALUATION
Kanhu Charan
 
Cross sectional study-dr.wah
Cross sectional study-dr.wahCross sectional study-dr.wah
Cross sectional study-dr.wah
Mmedsc Hahm
 
Odds ratio
Odds ratioOdds ratio
Odds ratio
Madhur Bora
 
Cohort study
Cohort studyCohort study
Cohort study
mgmcricommunitymed
 

What's hot (20)

Odds ratios (Basic concepts)
Odds ratios (Basic concepts)Odds ratios (Basic concepts)
Odds ratios (Basic concepts)
 
Chi-square, Yates, Fisher & McNemar
Chi-square, Yates, Fisher & McNemarChi-square, Yates, Fisher & McNemar
Chi-square, Yates, Fisher & McNemar
 
Pearson Correlation, Spearman Correlation &Linear Regression
Pearson Correlation, Spearman Correlation &Linear RegressionPearson Correlation, Spearman Correlation &Linear Regression
Pearson Correlation, Spearman Correlation &Linear Regression
 
1.5.3 measures prevalence
1.5.3 measures prevalence1.5.3 measures prevalence
1.5.3 measures prevalence
 
Epidemiological study designs
Epidemiological study designsEpidemiological study designs
Epidemiological study designs
 
Causal Inference PowerPoint
Causal Inference PowerPointCausal Inference PowerPoint
Causal Inference PowerPoint
 
Sample size calculation final
Sample size calculation finalSample size calculation final
Sample size calculation final
 
Study design
Study designStudy design
Study design
 
Screening
ScreeningScreening
Screening
 
Chapter 2.2 screening test
Chapter 2.2 screening testChapter 2.2 screening test
Chapter 2.2 screening test
 
Nested case control study
Nested case control studyNested case control study
Nested case control study
 
Reliability and validity
Reliability and validityReliability and validity
Reliability and validity
 
Introduction to Epidemiology and Surveillance
Introduction to Epidemiology and SurveillanceIntroduction to Epidemiology and Surveillance
Introduction to Epidemiology and Surveillance
 
Cross-Sectional Study.pptx
Cross-Sectional Study.pptxCross-Sectional Study.pptx
Cross-Sectional Study.pptx
 
Association and causation
Association and causationAssociation and causation
Association and causation
 
Measuring Disease Frequency
Measuring Disease FrequencyMeasuring Disease Frequency
Measuring Disease Frequency
 
ODDS RATIO AND RELATIVE RISK EVALUATION
ODDS RATIO AND RELATIVE RISK EVALUATIONODDS RATIO AND RELATIVE RISK EVALUATION
ODDS RATIO AND RELATIVE RISK EVALUATION
 
Cross sectional study-dr.wah
Cross sectional study-dr.wahCross sectional study-dr.wah
Cross sectional study-dr.wah
 
Odds ratio
Odds ratioOdds ratio
Odds ratio
 
Cohort study
Cohort studyCohort study
Cohort study
 

Similar to Likelihood Ratio, ROC and kappa

screening and diagnostic testing
screening and diagnostic  testingscreening and diagnostic  testing
screening and diagnostic testing
amitakashyap1
 
Screening and diagnostic testing
Screening and diagnostic  testingScreening and diagnostic  testing
Screening and diagnostic testing
amitakashyap1
 
Diagnostic testing 2009
Diagnostic testing 2009Diagnostic testing 2009
Diagnostic testing 2009
coolboy101pk
 
Sensitivity, specificity and likelihood ratios
Sensitivity, specificity and likelihood ratiosSensitivity, specificity and likelihood ratios
Sensitivity, specificity and likelihood ratios
Chew Keng Sheng
 
Probability.pdf.pdf and Statistics for R
Probability.pdf.pdf and Statistics for RProbability.pdf.pdf and Statistics for R
Probability.pdf.pdf and Statistics for R
SakhileKhoza2
 
Evidence Based Diagnosis
Evidence Based DiagnosisEvidence Based Diagnosis
Evidence Based Diagnosis
Karl Daniel, M.D.
 
Evidence-based diagnosis
Evidence-based diagnosisEvidence-based diagnosis
Evidence-based diagnosis
Hesham Gaber
 
Diagnotic and screening tests
Diagnotic and screening testsDiagnotic and screening tests
Diagnotic and screening tests
jfwilson2
 
05 diagnostic tests cwq
05 diagnostic tests cwq05 diagnostic tests cwq
05 diagnostic tests cwq
Sumit Prajapati
 
Validity and Screening Test
Validity and Screening TestValidity and Screening Test
Validity and Screening Test
Dr. Abraham Mallela
 
VALIDITY AND RELIABLITY OF A SCREENING TEST seminar 2.pptx
VALIDITY AND RELIABLITY OF A SCREENING TEST seminar 2.pptxVALIDITY AND RELIABLITY OF A SCREENING TEST seminar 2.pptx
VALIDITY AND RELIABLITY OF A SCREENING TEST seminar 2.pptx
ShaliniPattanayak
 
Peds journal club 2 -diagnostic test
Peds journal club 2 -diagnostic testPeds journal club 2 -diagnostic test
Peds journal club 2 -diagnostic test
coolboy101pk
 
Screening of diseases
Screening of diseasesScreening of diseases
Screening of diseases
PrateekGoyal67
 
OAJ presentation final draft
OAJ presentation final draftOAJ presentation final draft
OAJ presentation final draft
Brian Eisen
 
Validity of a screening test
Validity of a screening testValidity of a screening test
Validity of a screening test
drkulrajat
 
Measuring Diagnostic Accuracy
Measuring Diagnostic AccuracyMeasuring Diagnostic Accuracy
Measuring Diagnostic Accuracy
Long Hoàng
 
rational on clinical examination.pptx
rational on clinical examination.pptxrational on clinical examination.pptx
rational on clinical examination.pptx
BebikaPhuyal
 
session three epidemiology.pptx
session three epidemiology.pptxsession three epidemiology.pptx
session three epidemiology.pptx
AxmedAbdiHasen
 
session three epidemiology.pptx
session three epidemiology.pptxsession three epidemiology.pptx
session three epidemiology.pptx
AxmedAbdiHasen
 
Diagnosing a diagnostic april 08 2015
Diagnosing a diagnostic april 08 2015Diagnosing a diagnostic april 08 2015
Diagnosing a diagnostic april 08 2015
Athula Herath
 

Similar to Likelihood Ratio, ROC and kappa (20)

screening and diagnostic testing
screening and diagnostic  testingscreening and diagnostic  testing
screening and diagnostic testing
 
Screening and diagnostic testing
Screening and diagnostic  testingScreening and diagnostic  testing
Screening and diagnostic testing
 
Diagnostic testing 2009
Diagnostic testing 2009Diagnostic testing 2009
Diagnostic testing 2009
 
Sensitivity, specificity and likelihood ratios
Sensitivity, specificity and likelihood ratiosSensitivity, specificity and likelihood ratios
Sensitivity, specificity and likelihood ratios
 
Probability.pdf.pdf and Statistics for R
Probability.pdf.pdf and Statistics for RProbability.pdf.pdf and Statistics for R
Probability.pdf.pdf and Statistics for R
 
Evidence Based Diagnosis
Evidence Based DiagnosisEvidence Based Diagnosis
Evidence Based Diagnosis
 
Evidence-based diagnosis
Evidence-based diagnosisEvidence-based diagnosis
Evidence-based diagnosis
 
Diagnotic and screening tests
Diagnotic and screening testsDiagnotic and screening tests
Diagnotic and screening tests
 
05 diagnostic tests cwq
05 diagnostic tests cwq05 diagnostic tests cwq
05 diagnostic tests cwq
 
Validity and Screening Test
Validity and Screening TestValidity and Screening Test
Validity and Screening Test
 
VALIDITY AND RELIABLITY OF A SCREENING TEST seminar 2.pptx
VALIDITY AND RELIABLITY OF A SCREENING TEST seminar 2.pptxVALIDITY AND RELIABLITY OF A SCREENING TEST seminar 2.pptx
VALIDITY AND RELIABLITY OF A SCREENING TEST seminar 2.pptx
 
Peds journal club 2 -diagnostic test
Peds journal club 2 -diagnostic testPeds journal club 2 -diagnostic test
Peds journal club 2 -diagnostic test
 
Screening of diseases
Screening of diseasesScreening of diseases
Screening of diseases
 
OAJ presentation final draft
OAJ presentation final draftOAJ presentation final draft
OAJ presentation final draft
 
Validity of a screening test
Validity of a screening testValidity of a screening test
Validity of a screening test
 
Measuring Diagnostic Accuracy
Measuring Diagnostic AccuracyMeasuring Diagnostic Accuracy
Measuring Diagnostic Accuracy
 
rational on clinical examination.pptx
rational on clinical examination.pptxrational on clinical examination.pptx
rational on clinical examination.pptx
 
session three epidemiology.pptx
session three epidemiology.pptxsession three epidemiology.pptx
session three epidemiology.pptx
 
session three epidemiology.pptx
session three epidemiology.pptxsession three epidemiology.pptx
session three epidemiology.pptx
 
Diagnosing a diagnostic april 08 2015
Diagnosing a diagnostic april 08 2015Diagnosing a diagnostic april 08 2015
Diagnosing a diagnostic april 08 2015
 

More from amitakashyap1

Tortoise and hare story for leadership
Tortoise and hare story for leadershipTortoise and hare story for leadership
Tortoise and hare story for leadership
amitakashyap1
 
Leadership
Leadership Leadership
Leadership
amitakashyap1
 
Effective public health communication old
Effective public health communication oldEffective public health communication old
Effective public health communication old
amitakashyap1
 
Cohort design
Cohort designCohort design
Cohort design
amitakashyap1
 
Case control design
Case control designCase control design
Case control design
amitakashyap1
 
Effective public health communication 5th april
Effective public health communication 5th aprilEffective public health communication 5th april
Effective public health communication 5th april
amitakashyap1
 
Copper T insertion
Copper T insertionCopper T insertion
Copper T insertion
amitakashyap1
 
Contraceptive methods updated
Contraceptive methods updatedContraceptive methods updated
Contraceptive methods updated
amitakashyap1
 
Basic Concepts of PH
Basic Concepts of PHBasic Concepts of PH
Basic Concepts of PH
amitakashyap1
 
Basic Concepts of PH
Basic Concepts of PHBasic Concepts of PH
Basic Concepts of PH
amitakashyap1
 
Basic Concepts of PH
Basic Concepts of PHBasic Concepts of PH
Basic Concepts of PH
amitakashyap1
 
Basic Concepts PH
Basic Concepts PHBasic Concepts PH
Basic Concepts PH
amitakashyap1
 
Public Health and Its Role
Public Health and Its RolePublic Health and Its Role
Public Health and Its Role
amitakashyap1
 
Concepts 1 evolution of com med
Concepts 1 evolution of com medConcepts 1 evolution of com med
Concepts 1 evolution of com med
amitakashyap1
 
Concept of sufficient cause and component causes
Concept of sufficient cause and component causesConcept of sufficient cause and component causes
Concept of sufficient cause and component causes
amitakashyap1
 
Epidemiology Lectures for UG
Epidemiology Lectures for UGEpidemiology Lectures for UG
Epidemiology Lectures for UG
amitakashyap1
 
Epidemiology Lectures for UG
Epidemiology Lectures for UGEpidemiology Lectures for UG
Epidemiology Lectures for UG
amitakashyap1
 
Epidemiology Lectures for UG
Epidemiology Lectures for UGEpidemiology Lectures for UG
Epidemiology Lectures for UG
amitakashyap1
 
Epidemiology Lectures for UG
Epidemiology Lectures for UGEpidemiology Lectures for UG
Epidemiology Lectures for UG
amitakashyap1
 
Epidemiology Lectures for UG
Epidemiology Lectures for UGEpidemiology Lectures for UG
Epidemiology Lectures for UG
amitakashyap1
 

More from amitakashyap1 (20)

Tortoise and hare story for leadership
Tortoise and hare story for leadershipTortoise and hare story for leadership
Tortoise and hare story for leadership
 
Leadership
Leadership Leadership
Leadership
 
Effective public health communication old
Effective public health communication oldEffective public health communication old
Effective public health communication old
 
Cohort design
Cohort designCohort design
Cohort design
 
Case control design
Case control designCase control design
Case control design
 
Effective public health communication 5th april
Effective public health communication 5th aprilEffective public health communication 5th april
Effective public health communication 5th april
 
Copper T insertion
Copper T insertionCopper T insertion
Copper T insertion
 
Contraceptive methods updated
Contraceptive methods updatedContraceptive methods updated
Contraceptive methods updated
 
Basic Concepts of PH
Basic Concepts of PHBasic Concepts of PH
Basic Concepts of PH
 
Basic Concepts of PH
Basic Concepts of PHBasic Concepts of PH
Basic Concepts of PH
 
Basic Concepts of PH
Basic Concepts of PHBasic Concepts of PH
Basic Concepts of PH
 
Basic Concepts PH
Basic Concepts PHBasic Concepts PH
Basic Concepts PH
 
Public Health and Its Role
Public Health and Its RolePublic Health and Its Role
Public Health and Its Role
 
Concepts 1 evolution of com med
Concepts 1 evolution of com medConcepts 1 evolution of com med
Concepts 1 evolution of com med
 
Concept of sufficient cause and component causes
Concept of sufficient cause and component causesConcept of sufficient cause and component causes
Concept of sufficient cause and component causes
 
Epidemiology Lectures for UG
Epidemiology Lectures for UGEpidemiology Lectures for UG
Epidemiology Lectures for UG
 
Epidemiology Lectures for UG
Epidemiology Lectures for UGEpidemiology Lectures for UG
Epidemiology Lectures for UG
 
Epidemiology Lectures for UG
Epidemiology Lectures for UGEpidemiology Lectures for UG
Epidemiology Lectures for UG
 
Epidemiology Lectures for UG
Epidemiology Lectures for UGEpidemiology Lectures for UG
Epidemiology Lectures for UG
 
Epidemiology Lectures for UG
Epidemiology Lectures for UGEpidemiology Lectures for UG
Epidemiology Lectures for UG
 

Recently uploaded

Cervical Disc Arthroplasty ORSI 2024.pptx
Cervical Disc Arthroplasty ORSI 2024.pptxCervical Disc Arthroplasty ORSI 2024.pptx
Cervical Disc Arthroplasty ORSI 2024.pptx
LEFLOT Jean-Louis
 
Know the difference between Endodontics and Orthodontics.
Know the difference between Endodontics and Orthodontics.Know the difference between Endodontics and Orthodontics.
Know the difference between Endodontics and Orthodontics.
Gokuldas Hospital
 
Tele Optometry (kunj'sppt) / Basics of tele optometry.
Tele Optometry (kunj'sppt) / Basics of tele optometry.Tele Optometry (kunj'sppt) / Basics of tele optometry.
Tele Optometry (kunj'sppt) / Basics of tele optometry.
Kunj Vihari
 
Recent advances on Cervical cancer .pptx
Recent advances on Cervical cancer .pptxRecent advances on Cervical cancer .pptx
Recent advances on Cervical cancer .pptx
DrGirishJHoogar
 
NAVIGATING THE HORIZONS OF TIME LAPSE EMBRYO MONITORING.pdf
NAVIGATING THE HORIZONS OF TIME LAPSE EMBRYO MONITORING.pdfNAVIGATING THE HORIZONS OF TIME LAPSE EMBRYO MONITORING.pdf
NAVIGATING THE HORIZONS OF TIME LAPSE EMBRYO MONITORING.pdf
Rahul Sen
 
Medical Quiz ( Online Quiz for API Meet 2024 ).pdf
Medical Quiz ( Online Quiz for API Meet 2024 ).pdfMedical Quiz ( Online Quiz for API Meet 2024 ).pdf
Medical Quiz ( Online Quiz for API Meet 2024 ).pdf
Jim Jacob Roy
 
LOW BIRTH WEIGHT. PRETERM BABIES OR SMALL FOR DATES BABIES
LOW BIRTH WEIGHT. PRETERM BABIES OR SMALL FOR DATES BABIESLOW BIRTH WEIGHT. PRETERM BABIES OR SMALL FOR DATES BABIES
LOW BIRTH WEIGHT. PRETERM BABIES OR SMALL FOR DATES BABIES
ShraddhaTamshettiwar
 
Nano-gold for Cancer Therapy chemistry investigatory project
Nano-gold for Cancer Therapy chemistry investigatory projectNano-gold for Cancer Therapy chemistry investigatory project
Nano-gold for Cancer Therapy chemistry investigatory project
SIVAVINAYAKPK
 
CHEMOTHERAPY_RDP_CHAPTER 4_ANTI VIRAL DRUGS.pdf
CHEMOTHERAPY_RDP_CHAPTER 4_ANTI VIRAL DRUGS.pdfCHEMOTHERAPY_RDP_CHAPTER 4_ANTI VIRAL DRUGS.pdf
CHEMOTHERAPY_RDP_CHAPTER 4_ANTI VIRAL DRUGS.pdf
rishi2789
 
DECLARATION OF HELSINKI - History and principles
DECLARATION OF HELSINKI - History and principlesDECLARATION OF HELSINKI - History and principles
DECLARATION OF HELSINKI - History and principles
anaghabharat01
 
Physical demands in sports - WCSPT Oslo 2024
Physical demands in sports - WCSPT Oslo 2024Physical demands in sports - WCSPT Oslo 2024
Physical demands in sports - WCSPT Oslo 2024
Torstein Dalen-Lorentsen
 
Ageing, the Elderly, Gerontology and Public Health
Ageing, the Elderly, Gerontology and Public HealthAgeing, the Elderly, Gerontology and Public Health
Ageing, the Elderly, Gerontology and Public Health
phuakl
 
Cell Therapy Expansion and Challenges in Autoimmune Disease
Cell Therapy Expansion and Challenges in Autoimmune DiseaseCell Therapy Expansion and Challenges in Autoimmune Disease
Cell Therapy Expansion and Challenges in Autoimmune Disease
Health Advances
 
How to choose the best dermatologists in Indore.
How to choose the best dermatologists in Indore.How to choose the best dermatologists in Indore.
How to choose the best dermatologists in Indore.
Gokuldas Hospital
 
Pharmacology of 5-hydroxytryptamine and Antagonist
Pharmacology of 5-hydroxytryptamine and AntagonistPharmacology of 5-hydroxytryptamine and Antagonist
Pharmacology of 5-hydroxytryptamine and Antagonist
Dr. Nikhilkumar Sakle
 
Ophthalmic drugs latest. Xxxxxxzxxxxxx.pdf
Ophthalmic drugs latest. Xxxxxxzxxxxxx.pdfOphthalmic drugs latest. Xxxxxxzxxxxxx.pdf
Ophthalmic drugs latest. Xxxxxxzxxxxxx.pdf
MuhammadMuneer49
 
Top Travel Vaccinations in Manchester
Top Travel Vaccinations in ManchesterTop Travel Vaccinations in Manchester
Top Travel Vaccinations in Manchester
NX Healthcare
 
What are the different types of Dental implants.
What are the different types of Dental implants.What are the different types of Dental implants.
What are the different types of Dental implants.
Gokuldas Hospital
 
CBL Seminar 2024_Preliminary Program.pdf
CBL Seminar 2024_Preliminary Program.pdfCBL Seminar 2024_Preliminary Program.pdf
CBL Seminar 2024_Preliminary Program.pdf
suvadeepdas911
 
Post-Menstrual Smell- When to Suspect Vaginitis.pptx
Post-Menstrual Smell- When to Suspect Vaginitis.pptxPost-Menstrual Smell- When to Suspect Vaginitis.pptx
Post-Menstrual Smell- When to Suspect Vaginitis.pptx
FFragrant
 

Recently uploaded (20)

Cervical Disc Arthroplasty ORSI 2024.pptx
Cervical Disc Arthroplasty ORSI 2024.pptxCervical Disc Arthroplasty ORSI 2024.pptx
Cervical Disc Arthroplasty ORSI 2024.pptx
 
Know the difference between Endodontics and Orthodontics.
Know the difference between Endodontics and Orthodontics.Know the difference between Endodontics and Orthodontics.
Know the difference between Endodontics and Orthodontics.
 
Tele Optometry (kunj'sppt) / Basics of tele optometry.
Tele Optometry (kunj'sppt) / Basics of tele optometry.Tele Optometry (kunj'sppt) / Basics of tele optometry.
Tele Optometry (kunj'sppt) / Basics of tele optometry.
 
Recent advances on Cervical cancer .pptx
Recent advances on Cervical cancer .pptxRecent advances on Cervical cancer .pptx
Recent advances on Cervical cancer .pptx
 
NAVIGATING THE HORIZONS OF TIME LAPSE EMBRYO MONITORING.pdf
NAVIGATING THE HORIZONS OF TIME LAPSE EMBRYO MONITORING.pdfNAVIGATING THE HORIZONS OF TIME LAPSE EMBRYO MONITORING.pdf
NAVIGATING THE HORIZONS OF TIME LAPSE EMBRYO MONITORING.pdf
 
Medical Quiz ( Online Quiz for API Meet 2024 ).pdf
Medical Quiz ( Online Quiz for API Meet 2024 ).pdfMedical Quiz ( Online Quiz for API Meet 2024 ).pdf
Medical Quiz ( Online Quiz for API Meet 2024 ).pdf
 
LOW BIRTH WEIGHT. PRETERM BABIES OR SMALL FOR DATES BABIES
LOW BIRTH WEIGHT. PRETERM BABIES OR SMALL FOR DATES BABIESLOW BIRTH WEIGHT. PRETERM BABIES OR SMALL FOR DATES BABIES
LOW BIRTH WEIGHT. PRETERM BABIES OR SMALL FOR DATES BABIES
 
Nano-gold for Cancer Therapy chemistry investigatory project
Nano-gold for Cancer Therapy chemistry investigatory projectNano-gold for Cancer Therapy chemistry investigatory project
Nano-gold for Cancer Therapy chemistry investigatory project
 
CHEMOTHERAPY_RDP_CHAPTER 4_ANTI VIRAL DRUGS.pdf
CHEMOTHERAPY_RDP_CHAPTER 4_ANTI VIRAL DRUGS.pdfCHEMOTHERAPY_RDP_CHAPTER 4_ANTI VIRAL DRUGS.pdf
CHEMOTHERAPY_RDP_CHAPTER 4_ANTI VIRAL DRUGS.pdf
 
DECLARATION OF HELSINKI - History and principles
DECLARATION OF HELSINKI - History and principlesDECLARATION OF HELSINKI - History and principles
DECLARATION OF HELSINKI - History and principles
 
Physical demands in sports - WCSPT Oslo 2024
Physical demands in sports - WCSPT Oslo 2024Physical demands in sports - WCSPT Oslo 2024
Physical demands in sports - WCSPT Oslo 2024
 
Ageing, the Elderly, Gerontology and Public Health
Ageing, the Elderly, Gerontology and Public HealthAgeing, the Elderly, Gerontology and Public Health
Ageing, the Elderly, Gerontology and Public Health
 
Cell Therapy Expansion and Challenges in Autoimmune Disease
Cell Therapy Expansion and Challenges in Autoimmune DiseaseCell Therapy Expansion and Challenges in Autoimmune Disease
Cell Therapy Expansion and Challenges in Autoimmune Disease
 
How to choose the best dermatologists in Indore.
How to choose the best dermatologists in Indore.How to choose the best dermatologists in Indore.
How to choose the best dermatologists in Indore.
 
Pharmacology of 5-hydroxytryptamine and Antagonist
Pharmacology of 5-hydroxytryptamine and AntagonistPharmacology of 5-hydroxytryptamine and Antagonist
Pharmacology of 5-hydroxytryptamine and Antagonist
 
Ophthalmic drugs latest. Xxxxxxzxxxxxx.pdf
Ophthalmic drugs latest. Xxxxxxzxxxxxx.pdfOphthalmic drugs latest. Xxxxxxzxxxxxx.pdf
Ophthalmic drugs latest. Xxxxxxzxxxxxx.pdf
 
Top Travel Vaccinations in Manchester
Top Travel Vaccinations in ManchesterTop Travel Vaccinations in Manchester
Top Travel Vaccinations in Manchester
 
What are the different types of Dental implants.
What are the different types of Dental implants.What are the different types of Dental implants.
What are the different types of Dental implants.
 
CBL Seminar 2024_Preliminary Program.pdf
CBL Seminar 2024_Preliminary Program.pdfCBL Seminar 2024_Preliminary Program.pdf
CBL Seminar 2024_Preliminary Program.pdf
 
Post-Menstrual Smell- When to Suspect Vaginitis.pptx
Post-Menstrual Smell- When to Suspect Vaginitis.pptxPost-Menstrual Smell- When to Suspect Vaginitis.pptx
Post-Menstrual Smell- When to Suspect Vaginitis.pptx
 

Likelihood Ratio, ROC and kappa

  • 1. Continue Dx Test Evaluation DR Amita Kashyap Sr. Prof. PSM SMS Med College Jaipur
  • 2. Decide whether to order ESR or directly do MRI? • A 57 yr old man presents with h/o aching low back pain that persists at rest and is worse by bending and lifting. • Progressively getting worse in last 6 wks-waking from sleep. • Within past 10 days he has noticed numbness in Rt buttock and thigh and weakness in Rt lower limb. • He had no fever but has lost 10 lb Wt. in last 4 months. • O/E Temp. is 99.6F, tenderness in the lower lumber spine, decrease sensation over dorso-lateral aspect of Rt. foot, weakness in Rt ankle aversion. Deep tendon reflexes Norm. • You suspect that man has 20% chance of spinal Malignancy • ESR ≥20 mm/h has 78% sensitivity & 67% specificity • MRI has 95% sensitivity AND 95% specificity!! • Suppose we have 1000 patients
  • 3. We can use any of the following methods • 2 X 2 Table Method • Likelihood Ratio (gives odds) • Decision Tree method And • Bayes Theoram
  • 4. How will the prior probability of 20% Change with +ve ESR (78% sensitivity & 67% specificity) 2X2 Table method Disease Test (ESR) D+ D- T+ (TP) 156 (FP) 264 420 T- (FN) 44 (TN) 536 580 200 800 1000 Predictive Value of a Positive test PPV (PV+) = 156/420 = 0.37 Increased from 20% to 37% Predictive Value of a Negative test NPV = 536/580 = 0.92 A) - What is the probability of FP Rate ? B)- What is the probability of FN Rate? A) - 264/420 = 0.63 (hence minimal use as screening test), B) - 44/580 = 0.08
  • 5. MRI has 95% sensitivity AND 95% specificity And will have PVs as follows:- Disease Test (MRI) D+ D- T+ (TP) 351.5 (FP) 31.5 383 T- (FN) 18.5 (TN) 598.5 617 370 630 1000 PPV (PV+) = 351.5/383 = 0.918 FP Rate = 31.5/383 = 0.08 NPV (NPV) = 598.5/617= 0.970 FN Rate = 18.5/ 617 = 0.03
  • 6. • Definition: An LR is the probability of a particular test result for a persons with the disease divided by the probability of that test result in non-diseased persons How will the prior probability of 20% change with +ve ESR? Likelihood Ratio Method LR+ = Probability of +ve test result in Diseased persons (True positive / total diseased i.e. Sensitivity) Probability of +ve test result in Disease Free persons (False positive/ total Non-diseased i.e. 1- Specificity) LR¯ = Probability of -ve test result in Diseased persons (False Negative / total diseased i.e. 1- Sensitivity) Probability of -ve test result in Disease Free persons (True negatives/ total Non-diseased i.e. Specificity)
  • 7. LR+ = Sensitivity / 1-specificity = 0.78 / 1-0.67 = 0.78 / 0.33 = 2.36 LR¯ - 1-Sensitivity) / Specificity = 1- 0.78 / 0.67 = 0.22/ 0.67 = 0.328 With ESR having 78% sensitivity & 67% specificity
  • 8. Pre Test odds = Prior Probability 1- Prior Probability Post Test odds = LR X Pre test odds = 2.36 X 0.25 = 0.59 Posterior probability (PPV) = post test odds/ 1+ post test odds = 0.59/ 1+ 0.59 = 0.37 = 37% Likelihood Ratio to Post Test Probability = 0.20 /1- 0.2 = 0.25 Pre Test odds (with 20% Prev)
  • 9. 0.3 13 20 40 60 80 100 64 After positive FNA result 54 yr old women Before Mammogram After positive mammogram Probability of Breast Cancer (Percent) palpable lump Prior to mammogram Estimated Probability of Breast Cancer 1) In a 54 yr old women without palpable Breast Mass, 2) After a positive mammogram and 3) Following a positive FNA test result 1% with H/o Br Ca In mother
  • 10. How will the prior probability of 13% Change 2X2 Table method Surgical Biopsy Cancer No Cancer FNA Result + - Total 15 99 22 92 114 Total Prevalence = 13% Sensitivity = 93% Specificity = 92% PPV = 64% NPV = 99%
  • 11. LR+ = Sensitivity / 1-specificity = 0.93 / 1-0.92 = 0.93 / 0.08 = 11.63 LR¯ - 1-Sensitivity) / Specificity = 1- 0.93 / 0.92 = 0.07/ 0.92 = 0.08 With FNA having 93% sensitivity & 92% specificity In contrast to PV, LR does not vary as a function of Prevalence
  • 12. Pre Test odds = Prior Probability 1- Prior Probability Post Test odds = LR X Pre test odds = 11.63 X 0.15 = 1.74 Posterior probability (PPV) = post test odds/ 1+ post test odds = 1.74/ 1+ 1.74 = 0.64 = 64% Likelihood Ratio to Post Test Probability = 0.13 /1- 0.13 = 0.15 Pre Test odds (with 13 % Prev)
  • 13. Receiver Operating Characteristic (ROC) Curve • Diagnostic tests giving quantitative outcome e.g. serum levels of enzymes, there are many options about where to set a cut off point – as the cut off point rises (from 200 to 250mg/dl for total cholesterol) the sensitivity will increase with a corresponding decrease in specificity. •To get a most suitable cutoff point at each cutoff point, sensitivity and (1- specificity) are calculated and plotted on ‘y’ and ‘x’ axis respectively along the full range of cutoff points
  • 14. Test Result without the disease with the disease ‘‘-’’ ‘‘+’’ Moving the Threshold: right
  • 15. Test Result without the disease with the disease ‘‘-’’ ‘‘+’’ Moving the Threshold: left
  • 24.
  • 25. True Positive Rate 0% 100% False Positive Rate 0 % 100% True Positive Rate 0% 100% False Positive Rate 0% 100% A good test: A poor test: ROC curve comparison
  • 26. Best Test: Worst test: True Positive Rate 0 % 100% False Positive Rate 0 % 100 % True Positive Rate 0 % 100% False Positive Rate 0 % 100 % The distributions don’t overlap at all The distributions overlap completely ROC curve extremes
  • 27. Reliability or Repeatability of a Test • Factors responsible for variation in the results: 1. Intra subject (within the individual) variation 2. Intra observer variation (variation in the reading of test result by the same observer)- greater the subjective element in the reading more is this error 3. Inter observer variation (variation in the reading of test result between observers)
  • 28. Inter observer Variation Reading No. 1 Reading No. 2 Abnormal Suspect Doubtful Normal Abnormal A B C D Suspect E F G H Doubtful I J K L Normal M N O P Percent Agreement = A + F + K + P Total readings X 100
  • 29. In general, most persons who are tested have Negative Test Result, & there is likely to be Considerable agreement on this Ob 1 Ob 1
  • 30. Kappa Statistics • The extent to which two observers (physician/ nurse/ radiologist/ Dx Test) agree is an important Index of good quality of care • Yet, there is a fraction based ‘solely on chance’ for agreement between two observers • What we want to know is – to what extent did the education/ training that the observers received improve the quality of their observation (how much increased percent agreement between them beyond chance! )
  • 31. Rationale of the kappa statistics • First find out– “how much better is the agreement between the observers’ readings than would be expected by chance” i.e. = (% agreement observed - % agreement expected by Chance alone) • We Know that the maximum improvement the observers can have than expected by chance is:- 100% - % agreement expected by Chance alone • Kappa Statistics expresses the extent to which the observed agreement exceeds chance agreement relative to maximum that the observer can hope to improve
  • 32. • Kappa = [Percent Agreement Observed] [ Percent Agreement expected by chance alone ] - [ Percent Agreement expected by chance alone ] 100% - Landis and Koch suggested that :- kappa greater than 0.75 = excellent agreement Kappa of 0.40 to 0.75 = intermediate to good agreement
  • 33. Histological grading Of lung cancer by two pathologist

Editor's Notes

  1. A decision must be reached on whether to order ESR or proceed directly with lumber MRI. It depends on – Prior probability of Spinal Malignancy The accuracy of ESR in detecting malignancy among who have it (sensitivity) its ability to label a person not having disease among disease free people (specificity)
  2. Application of probabilistic and statistical principles to individual patient is evidence based medicine evaluating new diagnostic procedures determining most cost effective approach evaluating available Tt options A physician’s best guess (index of suspicion that pt has the disease – prior probability) depends on knowledge of prev. and is revised upwards or downwards depending up on S/S and other characteristics like race/ age/ sex etc Decision to do test &/ or Tt depends on the risk of the Diagnostic test, the benefits of Tt to patient, the risk of Tt to patient with and without disease and the accuracy of the Test.
  3. The sizes of the two likelihood ratios indicate the strength of association btw a test result and likelihood of the disease A diagnostic test with a large LR+ value increases the suspicion of disease for patients with positive results – larger the size better is the diagnostic value of the test…arbitrarily a value of 10 is perceived as an indication of a test of high value for LR+ and  0.1 for LR-
  4. The ROC plot of a given test is obtained by calculating the sensitivity and specificity of every observed value, and then plotting sensitivity (on the Y axis) against 1 - specificity (on the X axis). A test that does not discriminate between normal and abnormal would give a diagonal straight line from the bottom left corner to the top right corner. All points on such a line represent a 1:1 ratio of true to false positives. An ideal test would give a rectangular plot passing from the origin at the bottom left hand corner towards top left hand corner at first and thence to the top right hand corner. In reality the ROC curves of many of the tests in common use fall in between these extremes. The cut-off point for deciding between normal and abnormal is selected arbitrarily where the ROC curve changes direction from being vertical to horizontal. The more the ROC curve arches into the upper left hand corner away from the diagonal, the better the test.
  5. If we ask two roadside persons to mark a set of X-rays as positive and negative indepently there will be some agreement between their readings just by chance Kappa statistics proposed by Cohen in 1960